Non-Vitamin K Antagonist Oral Anticoagulants : : A Concise Guide.
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | Cham : : Springer International Publishing AG,, 2015. ©2016. |
Year of Publication: | 2015 |
Edition: | 1st ed. |
Language: | English |
Online Access: | |
Physical Description: | 1 online resource (82 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 02936nam a22003853i 4500 | ||
---|---|---|---|
001 | 5006422746 | ||
003 | MiAaPQ | ||
005 | 20240229073838.0 | ||
006 | m o d | | ||
007 | cr cnu|||||||| | ||
008 | 240229s2015 xx o ||||0 eng d | ||
020 | |a 9783319254609 |q (electronic bk.) | ||
020 | |z 9783319254586 | ||
035 | |a (MiAaPQ)5006422746 | ||
035 | |a (Au-PeEL)EBL6422746 | ||
035 | |a (OCoLC)1066198411 | ||
040 | |a MiAaPQ |b eng |e rda |e pn |c MiAaPQ |d MiAaPQ | ||
050 | 4 | |a R1 | |
100 | 1 | |a Shantsila, Eduard. | |
245 | 1 | 0 | |a Non-Vitamin K Antagonist Oral Anticoagulants : |b A Concise Guide. |
250 | |a 1st ed. | ||
264 | 1 | |a Cham : |b Springer International Publishing AG, |c 2015. | |
264 | 4 | |c ©2016. | |
300 | |a 1 online resource (82 pages) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
505 | 0 | |a Intro -- Contents -- Chapter 1: Introduction -- 1.1 Overview of the Coagulation Cascade -- 1.2 Current Approaches to Anticoagulation -- 1.3 The Ideal Anticoagulant -- References -- Chapter 2: Direct Thrombin Inhibitors -- 2.1 Historical Excursus: Ximelagatran -- 2.2 Dabigatran Etexilate -- 2.2.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery -- 2.2.2 Venous Thromboembolism Treatment -- 2.2.3 Stroke Prevention in Atrial Fibrillation -- 2.2.4 Other Directions -- References -- Chapter 3: Factor Xa Inhibitors -- 3.1 Rivaroxaban -- 3.1.1 Venous Thromboembolism Prevention following Joint Surgery -- 3.1.2 Treatment of Venous Thromboembolism -- 3.1.3 Stroke Prevention in Atrial Fibrillation -- 3.1.4 Acute Coronary Syndromes -- 3.2 Apixaban -- 3.2.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery -- 3.2.2 Stroke Prevention in Atrial Fibrillation -- 3.2.3 Thromboprophylaxis in Other Clinical Settings -- 3.2.4 Treatment of Venous Thrombosis -- 3.2.5 Acute Coronary Syndrome -- 3.3 Edoxaban -- 3.3.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery -- 3.3.2 Stroke Prevention in Atrial Fibrillation -- 3.3.3 Treatment of Venous Thromboembolism -- 3.4 Emerging Factor Xa Inhibitors -- 3.4.1 Betrixaban -- 3.4.2 TTP889 -- References -- Chapter 4: Conclusions -- 4.1 Future Directions -- References. | |
588 | |a Description based on publisher supplied metadata and other sources. | ||
590 | |a Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. | ||
655 | 4 | |a Electronic books. | |
700 | 1 | |a LIP, Gregory. | |
776 | 0 | 8 | |i Print version: |a Shantsila, Eduard |t Non-Vitamin K Antagonist Oral Anticoagulants |d Cham : Springer International Publishing AG,c2015 |z 9783319254586 |
797 | 2 | |a ProQuest (Firm) | |
856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=6422746 |z Click to View |